Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
-
Published:2022-11
Issue:10364
Volume:400
Page:1704-1711
-
ISSN:0140-6736
-
Container-title:The Lancet
-
language:en
-
Short-container-title:The Lancet
Author:
Vrselja AmandaORCID,
Latifi Ardian,
Baber Rodney JORCID,
Stuckey Bronwyn G AORCID,
Walker Michael G,
Stearns Vered,
Hickey MarthaORCID,
Davis Susan RORCID
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献